CERO THERAPEUTICS HOLDINGS, INC. (CERO) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $65.96M; Retained Earnings (Accumulated Deficit)USD $-97.75M; Stockholders' Equity Attributable to ParentUSD $-30.51M.
- 2026-03-31: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $80.29M; Retained Earnings (Accumulated Deficit)USD $-96.72M; Stockholders' Equity Attributable to ParentUSD $-9.26M.
- 2025-12-31: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $78.13M; Retained Earnings (Accumulated Deficit)USD $-90.84M; Stockholders' Equity Attributable to ParentUSD $-5.45M.
- 2025-09-30: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $73.06M; Retained Earnings (Accumulated Deficit)USD $-86.30M; Stockholders' Equity Attributable to ParentUSD $-4.54M.
CERO THERAPEUTICS HOLDINGS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Preferred Stock, Value, Outstanding USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD | Preferred Stock, Value, Issued USD | Retained Earnings, Appropriated USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $65.96M | $-97.75M | $-30.51M | $14.97M | (m) | (m) | 3 month · $21.58M | (m) | (m) | (m) |
| 2026-03-31 | (m) | $80.29M | $-96.72M | $-9.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $78.13M | $-90.84M | $-5.45M | (m) | (m) | 12 month · $1.10M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $73.06M | $-86.30M | $-4.54M | (m) | (m) | 3 month · $348.12K | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $71.31M | $-81.44M | $-1.63M | (m) | 3 month · $707.30K | 3 month · $183.33K | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $73.35M | $-76.02M | $-329.39K | (m) | (m) | (m) | (m) | 3 month · $85.50K | (m) | (m) |
| 2024-12-31 | (m) | $67.14M | $-70.92M | $-1.89M | (m) | (m) | (m) | (m) | 11 month · $85.50K 12 month · $85.50K | (m) | (m) |
| 2024-09-30 | (m) | $66.36M | $-71.59M | $-3.70M | (m) | (m) | 3 month · $414.74K | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $57.63M | $-67.36M | $-2.48M | (m) | (m) | 3 month · $1.39M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $53.99M | $-64.91M | $-3.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-02-14 | (m) | (m) | (m) | $-2.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $1.00 | $1.03M | $-43.09M | $-42.06M | (m) | (m) | (m) | (m) | (m) | (m) | $14.20M |
| 2023-09-30 | (m) | (m) | $-13.77M | $-13.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $88.00 | (m) | $-13.29M | $-13.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $0.00 | (m) | $-11.58M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2022-12-31 | $88.00 | $0.00 | $-11.00M | $-11.00M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2022-09-30 | (m) | $0.00 | (m) | $-9.06M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2022-06-30 | (m) | $0.00 | (m) | $-8.16M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2022-03-31 | (m) | (m) | (m) | $-8.05M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2021-12-31 | (m) | $0.00 | (m) | $-7.67M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2021-09-30 | (m) | $24.53K | (m) | $24.00K | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2021-06-30 | (m) | (m) | (m) | $24.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-07 | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |